
Bong-sook Baek
Examiner (ID: 19234, Phone: (571)270-5863 , Office: P/1621 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1629, 1614, 1611, 1621, 4161 |
| Total Applications | 1191 |
| Issued Applications | 499 |
| Pending Applications | 85 |
| Abandoned Applications | 621 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11471165
[patent_doc_number] => 20170057948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'INDOLE-LIKE TRK RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/249390
[patent_app_country] => US
[patent_app_date] => 2016-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 13332
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249390
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/249390 | INDOLE-LIKE TRK RECEPTOR ANTAGONISTS | Aug 26, 2016 | Abandoned |
Array
(
[id] => 13853879
[patent_doc_number] => 10188645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Methods and compositions for ameliorating symptoms of termination of opioid pain therapy
[patent_app_type] => utility
[patent_app_number] => 15/249085
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 15150
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/249085 | Methods and compositions for ameliorating symptoms of termination of opioid pain therapy | Aug 25, 2016 | Issued |
Array
(
[id] => 11471184
[patent_doc_number] => 20170057966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'FUSED HETEROCYCLIC COMPOUNDS AS S1P MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/248994
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 98744
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15248994
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/248994 | Fused heterocyclic compounds as S1P modulators | Aug 25, 2016 | Issued |
Array
(
[id] => 11336661
[patent_doc_number] => 20160362416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'ANTIVIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/246074
[patent_app_country] => US
[patent_app_date] => 2016-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35964
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15246074
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/246074 | ANTIVIRAL COMPOUNDS | Aug 23, 2016 | Abandoned |
Array
(
[id] => 11335549
[patent_doc_number] => 20160361305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'COMPOSITIONS AND METHODS COMPRISING BUPROPION OR RELATED COMPOUNDS FOR SUSTAINED DELIVERY OF DEXTROMETHORPHAN'
[patent_app_type] => utility
[patent_app_number] => 15/238182
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 51308
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15238182
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/238182 | COMPOSITIONS AND METHODS COMPRISING BUPROPION OR RELATED COMPOUNDS FOR SUSTAINED DELIVERY OF DEXTROMETHORPHAN | Aug 15, 2016 | Abandoned |
Array
(
[id] => 11894013
[patent_doc_number] => 09763932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects'
[patent_app_type] => utility
[patent_app_number] => 15/236290
[patent_app_country] => US
[patent_app_date] => 2016-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 51336
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15236290
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/236290 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Aug 11, 2016 | Issued |
Array
(
[id] => 13729643
[patent_doc_number] => 20180369289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => CELL TRANSPLANTATION DEVICE
[patent_app_type] => utility
[patent_app_number] => 15/747081
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747081 | CELL TRANSPLANTATION DEVICE | Aug 2, 2016 | Abandoned |
Array
(
[id] => 11554241
[patent_doc_number] => 20170100486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 15/222559
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 23903
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15222559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/222559 | Compounds and methods for trans-membrane delivery of molecules | Jul 27, 2016 | Issued |
Array
(
[id] => 11127832
[patent_doc_number] => 20160324807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'BUPROPION AS A MODULATOR OF DRUG ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/213283
[patent_app_country] => US
[patent_app_date] => 2016-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 50776
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15213283
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/213283 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | Jul 17, 2016 | Abandoned |
Array
(
[id] => 11127867
[patent_doc_number] => 20160324842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'METHOD OF PROVIDING PIRFENIDONE THERAPY TO A PATIENT'
[patent_app_type] => utility
[patent_app_number] => 15/212674
[patent_app_country] => US
[patent_app_date] => 2016-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5891
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15212674
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/212674 | METHOD OF PROVIDING PIRFENIDONE THERAPY TO A PATIENT | Jul 17, 2016 | Abandoned |
Array
(
[id] => 11393830
[patent_doc_number] => 20170014365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'Compositions Containing Very Long Chain Saturated Fatty Acids and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 15/210469
[patent_app_country] => US
[patent_app_date] => 2016-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7050
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15210469
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/210469 | Compositions Containing Very Long Chain Saturated Fatty Acids and Methods of Use | Jul 13, 2016 | Abandoned |
Array
(
[id] => 11335594
[patent_doc_number] => 20160361349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'APPLICATIONS OF PARTIALLY AND FULLY SULFATED HYALURONAN'
[patent_app_type] => utility
[patent_app_number] => 15/205093
[patent_app_country] => US
[patent_app_date] => 2016-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10673
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15205093
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/205093 | Applications of partially and fully sulfated hyaluronan | Jul 7, 2016 | Issued |
Array
(
[id] => 14403417
[patent_doc_number] => 20190167552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING THE APPEARANCE OF THE HAIR
[patent_app_type] => utility
[patent_app_number] => 16/313702
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313702 | Compositions and methods for improving the appearance of the hair | Jun 29, 2016 | Issued |
Array
(
[id] => 11106102
[patent_doc_number] => 20160303072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'VITAMINS C AND K FOR TREATING POLYCYSTIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/197560
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33788
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15197560
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/197560 | Vitamins C and K for treating polycystic diseases | Jun 28, 2016 | Issued |
Array
(
[id] => 14230829
[patent_doc_number] => 20190127587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => SO2 Containing Dispersion With High Salt Stability
[patent_app_type] => utility
[patent_app_number] => 15/743214
[patent_app_country] => US
[patent_app_date] => 2016-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15743214
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/743214 | SO2 Containing Dispersion With High Salt Stability | Jun 27, 2016 | Abandoned |
Array
(
[id] => 11106149
[patent_doc_number] => 20160303119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE'
[patent_app_type] => utility
[patent_app_number] => 15/192729
[patent_app_country] => US
[patent_app_date] => 2016-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4204
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15192729
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/192729 | Combination of brimonidine and timolol for topical ophthalmic use | Jun 23, 2016 | Issued |
Array
(
[id] => 15423037
[patent_doc_number] => 10544434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Process for the preparation of lisdexamfetamine and related derivatives
[patent_app_type] => utility
[patent_app_number] => 15/182698
[patent_app_country] => US
[patent_app_date] => 2016-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19482
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15182698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/182698 | Process for the preparation of lisdexamfetamine and related derivatives | Jun 14, 2016 | Issued |
Array
(
[id] => 11120502
[patent_doc_number] => 20160317476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects'
[patent_app_type] => utility
[patent_app_number] => 15/182253
[patent_app_country] => US
[patent_app_date] => 2016-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 50670
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15182253
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/182253 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Jun 13, 2016 | Issued |
Array
(
[id] => 13504857
[patent_doc_number] => 20180303971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => Absorbable Iron-Based Alloy Medical Instrument Implant and Manufacturing Method
[patent_app_type] => utility
[patent_app_number] => 15/767610
[patent_app_country] => US
[patent_app_date] => 2016-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767610
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767610 | Absorbable iron-based alloy medical instrument implant and manufacturing method | Jun 6, 2016 | Issued |
Array
(
[id] => 11090534
[patent_doc_number] => 20160287502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'METHOD FOR STRAIGHTENING, CONDITIONING AND COLOURING HAIR, ESPECIALLY HAIR WITH SUBSTANTIAL CURL'
[patent_app_type] => utility
[patent_app_number] => 15/175831
[patent_app_country] => US
[patent_app_date] => 2016-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14053
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15175831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/175831 | Method for straightening, conditioning and colouring hair, especially hair with substantial curl | Jun 6, 2016 | Issued |